Sutro to Present at 37th Annual J.P. Morgan Healthcare Conference

by Steve Michel | Jan 3, 2019 | Events, News, Press Releases

Sutro to Present at 37th Annual J.P. Morgan Healthcare Conference SOUTH SAN FRANCISCO, Calif., Jan. 3, 2019 –Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare...

Non-Confidential Corporate Presentation – JPM 2019

by Steve Michel | Jan 1, 2019 | Presentations

Non-Confidential Corporate Presentation – JPM...

Sutro Achieves $10 Million Milestone Payment from Celgene

by Steve Michel | Dec 19, 2018 | Press Releases

Sutro Achieves $10 Million Milestone Payment from Celgene Sutro develops successful spray drying technology marking a major advancement in commercial-scale manufacturing capabilities SOUTH SAN FRANCISCO, Calif., Dec. 19, 2018 — Sutro Biopharma, Inc. (NASDAQ:...

Sutro Biopharma Reports Third Quarter 2018 Financial Results

by Steve Michel | Nov 14, 2018 | Press Releases

Sutro Biopharma Reports Third Quarter 2018 Financial Results — STRO-001 Received Orphan Drug Designation for Treatment of Multiple Myeloma — STRO-002 to Begin Phase 1 Trial for Patients with Ovarian and Endometrial Cancers in Early 2019 SOUTH SAN...

12th Biennial Ovarian Cancer Research Symposium – STRO-002 Abstract

by Steve Michel | Sep 15, 2018 | Presentations

12th Biennial Ovarian Cancer Research Symposium – STRO-002 Abstract Objectives: Folate receptor alpha (FolRa) is a cell-surface glycoprotein, highly expressed in ovarian and endometrial adenocarcinoma, and is thus a promising target for cancer therapy using...